强调纳米结构脂质载体在抗生素眼部输送中的作用
Chandra Pratap Singh1,2, Pankaj Kumar Rai2, Manish Kumar3
1Usha college of Pharmacy & Medical Sciences, Vijaygaon, Ambedkar Nagar, 224122, UP, India.
Pharmaceutical nanotechnology
|July 31, 2023
概括
固体脂质纳米颗粒 (SLNPs) 提供一种安全有效的眼部药物输送方法,增强各种药物的吸收和生物可用性. 这种方法克服了与传统眼睛治疗相关的挑战.
科学领域:
- 眼科药物输送是眼科药物输送.
- 纳米技术在制药中的应用
- 生物相容的药物载体
背景情况:
- 由于眼睛的复杂解剖学,眼部药物输送面临着挑战.
- 系统性药物输送是有效的,但具有高剂量毒性风险.
- 传统的方法,如眼滴,效果有限.
研究的目的:
- 对纳米结构脂质载体 (NLCs) 进行审查,以改善眼部药物输送.
- 探索SLNP在提高眼部生物可用性的潜力.
- 为了解决传统眼科配方的局限性.
主要方法:
- 审查各种纳米配方技术用于眼部输送.
- 讨论乳化,超声波和融乳化方法.
- 对纳米结构脂质载体的特性和制造方法的分析.
主要成果:
- 从天然脂质中提取的SLNP是安全和无毒的.
- SLNP 增强角膜对水友和脂友药物的吸收.
- NLCs显示了眼部生物可用性和透率的改善.
结论:
- 表面修饰的NLCs与阴离子剂增加眼睛的生物可用性.
- 纳米结构配方为前后眼部药物输送提供了先进的解决方案.
- SLNP代表了眼科药物输送系统的有希望的进步.
相关概念视频
01:22Drug Delivery: Miscellaneous Routes
383
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
383
01:18Drug Delivery: Enteral Route
505
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
505